Skip to main
HKPD
HKPD logo

Hong Kong Pharma Digital Technology Holdings Ltd (HKPD)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy HKPD Stock

About Hong Kong Pharma Digital Technology Holdings Ltd (HKPD)

The full company name is Hong Kong Pharma Digital Technology Holdings Ltd.
Market cap
Today's volume474.99K
Revenue (TTM)
Avg. daily volume1.9M
EBITDA (TTM)
Open$1.52
Price / earnings ratio
Today's range$1.38 - $1.65
Debt / equity
52 week range$0.81 - $4
5 year debt / equity
Beta (LTM)0.91x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earnings
Dividend payable date

Frequently Asked Questions (FAQ)

The 52-week high for HKPD stock is $4. The current HKPD stock price $undefined is 100.00% below its 52-week high

The 52-week low for HKPD stock is $0.81. The current HKPD stock price $undefined has increased 100.00% from its 52-week low

No, the HKPD stock does not pay dividends to its shareholders

How to buy HKPD stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in HKPD stock

    Navigate to the Explore page. Then, type HKPD into the search bar. When you see HKPD stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased HKPD stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Buy HKPD Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.